Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Heart (British Cardiac Society)|January 2, 2026
Prehospital risk stratification in suspected non-ST-segment elevation acute coronary syndrome with point-of-care troponin: an individual patient data meta-analysisJesse Demandt, Dennis Sagel, Cyril Camaro, et al.European Heart Journal|August 31, 2010
A single dose of erythropoietin in ST-elevation myocardial infarctionAdriaan A Voors, Anne M S Belonje, Felix Zijlstra, et al.European Heart Journal. Acute Cardiovascular Care|August 26, 2017
Clinical impact and predictors of complete ST segment resolution after primary percutaneous coronary intervention: A subanalysis of the ATLANTIC TrialEnrico Fabris, Arnoud van 't Hof, Christian W Hamm, et al.American Heart Journal|November 26, 2013
Design and methods of European Ambulance Acute Coronary Syndrome Angiography Trial (EUROMAX): an international randomized open-label ambulance trial of bivalirudin versus standard-of-care anticoagulation in patients with acute ST-segment-elevation myocardial infarction transferred for primary percutaneous coronary interventionPhilippe Gabriel Steg, Arnoud van 't Hof, Peter Clemmensen, et al.The New England Journal of Medicine|November 1, 2013
Bivalirudin started during emergency transport for primary PCIPhilippe Gabriel Steg, Arnoud van 't Hof, Christian W Hamm, et al.Journal of the Society for Cardiovascular Angiography & Interventions|August 12, 2024
Patients With Diabetes at High Bleeding Risk With 1-Month Dual Antiplatelet Therapy: Onyx ONE Clear ResultsElvin Kedhi, Stephan Windecker, Azeem Latib, et al.American Heart Journal|February 28, 2016
Rationale and design of POPular-TAVI: antiPlatelet therapy fOr Patients undergoing Transcatheter Aortic Valve ImplantationVincent Johan Nijenhuis, Naoual Bennaghmouch, Mariella Hassell, et al.Lancet (London, England)|August 30, 2018
Radial versus femoral access and bivalirudin versus unfractionated heparin in invasively managed patients with acute coronary syndrome (MATRIX): final 1-year results of a multicentre, randomised controlled trialMarco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.Journal of the American College of Cardiology|March 17, 2018
Bivalirudin or Heparin in Patients Undergoing Invasive Management of Acute Coronary SyndromesGiuseppe Gargiulo, Greta Carrara, Enrico Frigoli, et al.The New England Journal of Medicine|September 2, 2015
Bivalirudin or Unfractionated Heparin in Acute Coronary SyndromesMarco Valgimigli, Enrico Frigoli, Sergio Leonardi, et al.Pageof 4